M Moriau

4.3k total citations
45 papers, 675 citations indexed

About

M Moriau is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, M Moriau has authored 45 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 17 papers in Cardiology and Cardiovascular Medicine and 14 papers in Hematology. Recurrent topics in M Moriau's work include Venous Thromboembolism Diagnosis and Management (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). M Moriau is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). M Moriau collaborates with scholars based in Belgium, Netherlands and United States. M Moriau's co-authors include Marc De Bruyère, E Lavenne-Pardonge, J Rodhain, A. Cordier, G. Sokal, Herman Van den Berghe, Jl. Michaux, J. Sonnet, A Ferrant and Dominique Latinne and has published in prestigious journals such as Blood, Diabetes Care and The American Journal of Cardiology.

In The Last Decade

M Moriau

42 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Moriau Belgium 14 249 231 121 95 92 45 675
Andrzej Rydzewski Poland 15 187 0.8× 166 0.7× 99 0.8× 37 0.4× 160 1.7× 57 612
Meera Sridharan United States 17 106 0.4× 142 0.6× 122 1.0× 85 0.9× 91 1.0× 62 906
RC Woodman Canada 9 217 0.9× 382 1.7× 232 1.9× 103 1.1× 77 0.8× 14 899
J. Fareed United States 14 210 0.8× 249 1.1× 207 1.7× 280 2.9× 62 0.7× 44 605
R. Großmann Germany 16 352 1.4× 239 1.0× 301 2.5× 203 2.1× 74 0.8× 36 785
Levent Ündar Türkiye 14 286 1.1× 76 0.3× 49 0.4× 17 0.2× 23 0.3× 55 627
Kenji Okajima Japan 9 284 1.1× 114 0.5× 69 0.6× 84 0.9× 90 1.0× 10 656
I. Juhan-Vague France 11 190 0.8× 114 0.5× 173 1.4× 81 0.9× 172 1.9× 26 868
Annika E. Michelsen Norway 16 103 0.4× 119 0.5× 114 0.9× 18 0.2× 81 0.9× 63 833
Franco Carmassi Italy 12 130 0.5× 123 0.5× 194 1.6× 62 0.7× 133 1.4× 34 739

Countries citing papers authored by M Moriau

Since Specialization
Citations

This map shows the geographic impact of M Moriau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Moriau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Moriau more than expected).

Fields of papers citing papers by M Moriau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Moriau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Moriau. The network helps show where M Moriau may publish in the future.

Co-authorship network of co-authors of M Moriau

This figure shows the co-authorship network connecting the top 25 collaborators of M Moriau. A scholar is included among the top collaborators of M Moriau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Moriau. M Moriau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hainaut, Pierre, David Verhelst, Pierre Wallemacq, et al.. (2002). Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic cases. Thrombosis Research. 106(2). 121–125. 30 indexed citations
2.
Gala, Jean‐Luc, et al.. (1998). The Prothrombin Gene G20210A Variant in an Unselected Thromboembolic Population. A belgian prospective clinical study.. Acta Clinica Belgica. 53(5). 344–348. 4 indexed citations
3.
Hainaut, Pierre, F. Lehmann, Francis Zech, et al.. (1997). Prevalence of activated protein C resistance and analysis of clinical profile in thromboembolic patients. A Belgian prospective study. Journal of Internal Medicine. 241(5). 427–433. 11 indexed citations
4.
Lavenne-Pardonge, E, et al.. (1996). Case 5—1996 thrombosis after the use of a heparin-coated cardiopulmonary bypass circuit in a patient with heparin-induced thrombocytopenia. Journal of Cardiothoracic and Vascular Anesthesia. 10(6). 809–815. 3 indexed citations
5.
Moriau, M, et al.. (1996). ACQUIRED ACTIVATED PROTEIN C RESISTANCE IN PREGNANCY. Thrombosis Research. 84(3). 203–206. 16 indexed citations
6.
Moriau, M, et al.. (1995). The treatment of severe or recurrent deep venous thrombosis. Thrombosis Research. 78(6). 469–482. 8 indexed citations
7.
Wilson, J. A., et al.. (1994). Hydroxyethylrutosides in Elderly Patients with Chronic Venous Insufficiency: Its Efficacy and Tolerability. Gerontology. 40(1). 45–52. 22 indexed citations
8.
Moriau, M, et al.. (1993). Platelet anti-aggregant and rheological properties of piracetam. A pharmacodynamic study in normal subjects.. PubMed. 43(2). 110–8. 30 indexed citations
9.
Dion, Robert, et al.. (1990). A novel preservation medium protecting prostacyclin production and endothelial integrity of the human saphenous vein graft. Thrombosis Research. 57. 81–86. 12 indexed citations
10.
Col, Jacques, et al.. (1989). Pharmacokinetics, thrombolytic efficacy and hemorrhagic risk of different streptokinase regimens in heparin-treated acute myocardial infarction. The American Journal of Cardiology. 63(17). 1185–1192. 6 indexed citations
11.
Lavenne-Pardonge, E, et al.. (1988). 182 Anticoagulant and fibrinolytic effects of ionic contrast media in man. Fibrinolysis and Proteolysis. 2. 78–78. 1 indexed citations
12.
13.
Alexandre, Guy P., Yves Pirson, Jean‐Paul Squifflet, et al.. (1986). Abo-incompatible Related and Unrelated Living Donor Renal-allografts. Transplantation Proceedings. 18(5). 1090–1092. 18 indexed citations
14.
Alexandre, Guy P., Yves Pirson, Jean‐Paul Squifflet, et al.. (1985). Splenectomy As a Prerequisite for Successful Human Abo-incompatible Renal-transplantation. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 17(1). 138–143. 67 indexed citations
15.
Bosly, André, Bernard Châtelain, Chantal Doyen, & M Moriau. (1984). Plasma-exchange in Waldenstroms Disease - Efficacy and Comparison of Continuous Centrifugation, Discontinuous Centrifugation, and Filtration. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 5(3). 319–322. 2 indexed citations
16.
Moriau, M, et al.. (1982). Clinical and Biological Activity of the Antiplatelet Agent Suloctidil in Treatment of Idiopathic Recurrent Vein Thrombosis (I.R.V.T.). Thrombosis and Haemostasis. 47(1). 27–31. 8 indexed citations
17.
Moriau, M, Augustin Ferrant, A. Hurlet, et al.. (1977). Evaluation of the Antithrombotic Properties of Suloctidil in Patients with Substitute Heart Valves. Thrombosis and Haemostasis. 1 indexed citations
18.
19.
Otte, Jean-Bernard, Luc Lambotte, JP Squifflet, M Moriau, & Paul-Jacques Kestens. (1973). Successful Orthotopic Transplantation of the Canine Liver after Prolonged Preservation by Initial Perfusion and Cold Storage. European Surgical Research. 5(4). 273–281. 4 indexed citations
20.
Moriau, M, et al.. (1963). Les inhibiteurs de la fibrinolyse et le dosage de l’activité antiplasminique physiologique et pathologique. Thrombosis and Haemostasis. 10(2). 355–378. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrzej Rydzewski Breakdown of academic impact, for papers by Meera Sridharan Breakdown of academic impact, for papers by RC Woodman Breakdown of academic impact, for papers by J. Fareed Breakdown of academic impact, for papers by R. Großmann Breakdown of academic impact, for papers by Levent Ündar Breakdown of academic impact, for papers by Kenji Okajima Breakdown of academic impact, for papers by I. Juhan-Vague Breakdown of academic impact, for papers by Annika E. Michelsen Breakdown of academic impact, for papers by Franco Carmassi
Rankless by CCL
2026